- Reference code :
- wf348
- Published date :
-
11 October 2000
- Expired date :
-
27 February 2028
AstraZeneca PLC announces that, at its Extraordinary General Meeting held in London earlier today, shareholder approval was given for the declaration and payment by the AstraZeneca Board of a dividend of Syngenta shares to holders of AstraZeneca shares on the relevant record date. The approval of this dividend will facilitate implementation of the previously announced proposed demerger of Zeneca Agrochemicals and its merger with Novartis Agribusiness to form Syngenta.
At an Extraordinary General Meeting also held today in Switzerland, the Syngenta transaction was approved by the Novartis shareholders.
Completion of the transaction, which remains subject to US competition law approval, is presently anticipated to take place in mid-November.
Further enquires to:
|
Steve Brown +44 (0)20 7304 5033 Lucy Williams +44 (0)20 7304 5034 |
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 06:45 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
